Gara Jalqabaatti › Kansara Metastatikii › Texas › Dallas
Qorannoo klinikaalii Kansara Metastatikii Dallas, TX keessatti
Qorannoo 42 Kansara Metastatikii f Dallas fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Namoota walitti qabaa jiraSadarkaa 2
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Namoota walitti qabaa jiraSadarkaa 1/2
- UT Southwest Simmons Cancer Center, Dallas
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
Namoota walitti qabaa jiraSadarkaa 1
- Texas Oncology, Dallas
- University of Texas Southwestern Medical Center, Dallas
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- UT Southwestern, Dallas
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- SCRI at Mary Crowley, Dallas
- University of Texas Southwestern Medical Center, Dallas
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Namoota walitti qabaa jiraSadarkaa 2/3
- Texas Oncology- Baylor Charles A. Sammons Cancer Center, Dallas
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Dallas
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Namoota walitti qabaa jiraSadarkaa 2
- University of Texas Southwestern Medical Center, Dallas
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Namoota walitti qabaa jiraSadarkaa 1/2
- The University of Texas Southwestern Medical Center - Harold C Simmons Comprehensive Cancer Center, Dallas
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Namoota walitti qabaa jiraSadarkaa 2/3
- University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
- University of Texas Southwestern Medical Center-William P. Clements Jr. University Hospital, Dallas
- University of Texas Southwestern Medical Center-Zale Lipshy University Hospital, Dallas
- fi 1 dabalataa
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- NEXT Oncology, Dallas
- SCRI at Mary Crowley, Dallas
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Texas Oncology - DFW, Dallas
- Texas Oncology - DFW, Dallas
- Texas Oncology - DFW, Dallas
- fi 2 dabalataa
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Namoota walitti qabaa jiraSadarkaa 1
- Texas Oncology - DFW (Sammons CC), Dallas
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Namoota walitti qabaa jiraSadarkaa 3
- UT Southwestern Medical Center, Dallas
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Namoota walitti qabaa jiraSadarkaa 3
- Parkland Health and Hospital System, Dallas
- UT Southwestern Medical Center, Dallas
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Namoota walitti qabaa jiraSadarkaa 3
- Parkland Health and Hospital System, Dallas
- USO - Texas Oncology, Dallas
- UT Southwestern Medical Center, Dallas
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
- University of Texas Southwestern Medical Center-William P. Clements Jr. University Hospital, Dallas
- University of Texas Southwestern Simmons Cancer Center - Redbird, Dallas
- fi 2 dabalataa
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Clinical Study Site, Dallas
A Study of KK2269 in Adult Participants With Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- The University of Texas Southwestern Medical Center, Dallas
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Namoota walitti qabaa jiraSadarkaa 1/2
- Avenzo Therapeutics Recruiting Site, Dallas
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Namoota walitti qabaa jiraSadarkaa 3
- Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas
- Mary Crowley Cancer Research, Dallas
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- University of Texas Southwestern Medical Center, Dallas
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Namoota walitti qabaa jiraSadarkaa 1
- University of Texas Southwestern, Dallas
- Texas Oncology, P.A, Dallas
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Mary Crowley Cancer Research, Dallas
- Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas
A Study of ASP1002 in Adults for Treatment of Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Mary Crowley Cancer Research Center, Dallas
A Study of PYX-201 in Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- NEXT Dallas, Dallas
Feasibility Study of Personalized Ultra-fractionated Stereotactic Ablative Radiotherapy (PULSAR) for Cancers of the Central Lung
Namoota walitti qabaa jiraSadarkaa jalqabaa 1
- University of Texas Southwestern Medical Center, Dallas
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Namoota walitti qabaa jiraSadarkaa 3
- Old Parkland Hospital Hematology Oncology Clinic, Dallas
- UT Southwestern Medical Center, Dallas
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Sarah Cannon Research Institute at Mary Crowley, Dallas
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
Namoota walitti qabaa jiraSadarkaa 1
- Sarah Cannon Research Institute at Mary Crowley, Dallas
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Namoota walitti qabaa jiraSadarkaa 1/2
- Mary Crowley Cancer Research, Dallas
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Namoota walitti qabaa jiraSadarkaa 2/3
- UT Southwestern Medical Center, Dallas
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
Namoota walitti qabaa jiraSadarkaa 1/2
- Next Oncology, Dallas
- UTSW Medical Center, Dallas
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- NEXT Dallas, Dallas
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- NEXT Oncology - Dallas, Dallas
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Namoota walitti qabaa jiraSadarkaa 1
- Mary Crowley Cancer Research, Dallas
- Baylor University Medical Center, Dallas
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 1
- Urology Clinics of North Texas, Dallas
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Texas Oncology - Baylor Charles A Sammons Cancer Center, Dallas
Radiotherapy in Combination With Checkpoint Inhibition for Patients With Metastatic Kidney Cancer
Namoota walitti qabaa jiraSadarkaa 2
- University of Texas Southwestern Medical Center, Dallas
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, Dallas
Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Mary Crowley Cancer Research, Dallas
ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)
Namoota walitti qabaa jiraSadarkaa 1
- Texas Oncology, Dallas
Qorannoo Kansara Metastatikii magaalota biroo keessatti
- Houston, TXQorannoo 104
- New York City, NYQorannoo 93
- Nashville, TNQorannoo 70
- Boston, MAQorannoo 63
- Los Angeles, CAQorannoo 57
- St. Louis, MOQorannoo 54
- Arlington, VAQorannoo 53
- Philadelphia, PAQorannoo 46
- Chicago, ILQorannoo 45
- San Antonio, TXQorannoo 44
- Washington, DCQorannoo 43
- Seattle, WAQorannoo 39
Qorannoo biroo Dallas keessatti
- Saree OljooQorannoo 55
- Kansara Qara'a Non-Small CellQorannoo 52
- Cufama OnneeQorannoo 42
- Saree (Gosoota Hunda)Qorannoo 37
- Kansarii ProstateQorannoo 36
- Kansarii ColorectalQorannoo 33
- ObesityQorannoo 30
- Kansarii OvariiQorannoo 28
- Dhibee QaraQorannoo 27
- Dukkana BladderQorannoo 27
- Kansa EndometiriyaaliiQorannoo 24
- Kansara Harkaa (Karsinomaa Seli Renal)Qorannoo 23
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.